May 19–22, 2015. Paris, France
CORolla® clinical study Kick-off workshop was held in MultiMedica, Milano.
San Francisco, California - CorAssist presents at the TCT 2013 Conference the 6 months follow-up results of first patient implanted with the CORolla® device, which indicate device safety, together with improvement in diastolic function parameters.
CorAssist receives the Italian Ministry of Health approval for conducting clinical study in Italy for its CORolla® TAA device for HFpEF.
CorAssist Cardiovascular announces first patient treated with the CORolla® TAA implant.
Two years results of the CORolla® pre clinical study demonstrating safety before entering the clinical stage
CorAssist raises $4.8 Million from its current shareholders
One year results of the CORolla pre clinical study demonstrating safety
CorAssists is awarded the “Best Technology Parade Presentation” in the ICI 2011 Conference.
CorAssists is awarded the “Best Technology Parade Presentation” in the ICI 2010 Conference.
CorAssist presents 24 Months Safety in Humans and demonstrated trends of efficacy
Implantation Demonstration Brings CORolla™ One Step Closer to the Clinic
Events and presentations
October 27 – November 1, 2013. San Francisco, California
May 30 – June 2, 2012. Los Angeles, California
October 22-26, 2012. Miami, Florida
December 4-6, 2011. Tel Aviv, Israel
November 7-11, 2011. San Francisco, California
ILSI BioMed 2011
May 23-25, 2011. Tel Aviv, Israel
May 17–20, 2011. Paris, France